New stem cell method aims to protect kids with rare immune disease
NCT ID NCT02737384
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a way to improve stem cell transplants for children with combined immunodeficiency (CID), a condition where the immune system doesn't work properly. The approach removed certain naive cells from the donor stem cells to try to prevent graft-versus-host disease (a serious complication) while keeping the donor's memory T cells to fight infections. Only 4 children were enrolled before the study ended early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMBINED IMMUNODEFICIENCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Necker-Enfants Malades
Paris, Paris, 75015, France